Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. - Wikidata - wikimedia - TriplyDB

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

http://www.wikidata.org/entity/Q36611620

about

Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapy.Progress in matrix metalloproteinase research.The role of viral and bacterial pathogens in gastrointestinal cancer.Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants.Helicobacter pylori and gastric cancer: factors that modulate disease risk.Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer.No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis.Association of MMP7 -181A→G Promoter Polymorphism with Gastric Cancer Risk: INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB).MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.MMP 9 Gene Promoter Polymorphism in Gastric Cancer.Association of MMP1-1607 1G/2G and TIMP1 372 T/C gene polymorphisms with risk of primary open angle glaucoma in a Polish population MMP-7 A-181G Polymorphism in Breast Cancer Patients from Western Iran Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7.Helicobacter and gastric malignancies.Genetic polymorphisms in the MMP-7 gene and breast cancer survival Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.A/G polymorphism of matrix metalloproteinase 7 gene promoter region and cancer risk: A meta-analysis.Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients.Diagnostic and prognostic role of matrix metalloproteases in cancer.Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis.Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review.Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus.MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis.Proteolysis in Helicobacter pylori-Induced Gastric Cancer.Regulation of MMP-2 expression and activity by β-1,3-N-acetylglucosaminyltransferase-8 in AGS gastric cancer cells.Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells.Relationship between single-nucleotide polymorphism of matrix metalloproteinase-2 gene and colorectal cancer and gastric cancer susceptibility: a meta-analysis.Matrix metalloproteinase 9 gene polymorphisms are associated with a multiple family history of gastric cancer.The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis.The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis.Gene polymorphisms of the MMP1, MMP9, MMP12, IL-1β and TIMP1 and the risk of primary open-angle glaucoma.Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.

P2860

Q33398142-3AFA406C-F8CC-49A7-A720-4799DC4E6954 Q33608536-DC4B9942-DAB0-4DDE-A132-6E6A03C4142C Q33791751-65A214DD-29B4-4BAE-877B-1ED1D04FD15B Q33952599-BE291214-76B8-45B2-9C86-06E88B302F18 Q34161592-D76279F3-E050-4605-852F-39D51D596DA3 Q34189885-9F8BFC6A-8A85-4C41-991D-D7177B050F3E Q34224754-AD7BB5A8-3747-465C-9A9C-DCA6CC1C11AF Q34243610-7F5F9B9F-53E4-4FF0-93DD-B7A8B9BD9903 Q35227828-854BF54A-4CFD-4B84-94E1-8678F0178A07 Q35860763-737776A0-7973-4B8A-8FCE-A4B7DD2FE787 Q35927127-C968A872-495B-4D28-8AAF-068C1747B09A Q36075298-9195210C-552A-4B99-B0DF-8479CA36A029 Q36079981-3C31E3BC-EF72-43FA-BBEC-3C5E15391780 Q36516522-DE7035A7-661C-4F7D-B5D2-08F997726158 Q36682410-E91B7ABE-82C9-450F-B251-3FEA025CE58C Q36805538-AE14CC06-C2BB-4010-9A99-77AF10252250 Q36914258-3141DF9B-55B1-4E6C-9791-1A63B2A03BC1 Q36922393-0FD265C0-0B0E-41FF-B04D-4D43C4763A5B Q37003874-ECC93F08-926E-43EA-AA21-2CCBC93FD042 Q37282674-6216BDBA-86C5-40A3-9122-EB1ABA284123 Q37565442-6EF60D5C-A97D-49F7-8112-9767D158A739 Q37615018-63724718-13DD-4F73-911A-DA0D1F13CB2B Q37692836-DE7FAE0E-1895-4337-B1A0-ECA7662B17DD Q38089795-CDB362FA-F107-464B-B28F-37B8E0EDAA35 Q38104242-C4FEA08C-A1ED-4786-8A35-FA916CA9027C Q38119975-52F2ABC9-2E76-4446-BC4A-31BB119D5BAC Q38794745-8619A66C-E5AB-4B58-A091-A8356A4FAE37 Q38805508-C4A53BF6-15F9-4B2F-BDEA-3804540FDBCA Q39188426-65C14CAF-047B-4552-BD2F-6755AB3233E8 Q39234154-BC78A56C-3CDB-4674-BE87-CC8E917E9329 Q39641629-6EA3B414-C3E6-46BE-9AB4-C4FEDC384E2F Q39833926-972EC2E8-C529-4883-B08D-F8C5FC73B1E8 Q39868071-E704CA51-81B9-474C-9905-A90B4F6372E7 Q40813749-98D39D76-548E-4F93-BEC0-DC8EAEBA4DF0 Q40912702-15353A35-2D1E-4EC1-BEF4-3AA2A0C861BF Q41504736-F4166254-AF6F-47C8-B217-8F8AF18D422A Q47156148-D78D9BCC-5664-48BE-AD62-297229B9F995 Q50879206-E1038B7F-A113-4120-A3FA-853114E5D42B Q51141692-8E27A67D-C26B-44FE-A4AE-70EAF01997B7 Q53086095-05532909-E0FF-4544-9ABF-E51E8C957FB9

P2860

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

http://www.wikidata.org/entity/Q36611620

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

@ast

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

@en

type

label

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

@ast

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

@en

prefLabel

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

@ast

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

@en

P1433

Q36611620-EDEED20B-F689-482C-B417-589383CA4847

P1476

Q36611620-FCD776C9-A7EF-416E-A6C3-857639AE2F00

P2093

Q36611620-1E9DCCC4-9830-4169-A85D-D9CC65428C32

Q36611620-28C494F6-50C3-4016-83FF-F396C74D4009

Q36611620-2EC8CC2E-05F5-4F45-BFE9-9D7A891C63AD

Q36611620-38E59AD3-F436-4F19-81B6-B98B7F2D6892

Q36611620-5BE8CBC1-C9E2-44AB-995C-75ED05B75CA0

Q36611620-6BD2FD7E-E992-4A9C-A582-E1E23E227315

Q36611620-A6F86F79-DB8F-4238-BD11-D55F35874F01

Q36611620-E5590F15-8815-4FA3-B91F-72C10D200F08

P2860

Q36611620-0058C725-622A-421D-912A-2A6022774E73

Q36611620-0D7956F8-CE7D-43CD-A6D1-3AE5BFB5F5EC

Q36611620-25C25D76-CEAC-44CA-A533-5C3C1D205E83

Q36611620-2A3883E0-D9E2-42B3-B43A-3016AEC7F158

Q36611620-3289B19E-5E28-4ACB-8A70-4A74EFEFD246

Q36611620-42776497-A9F2-4B17-8368-C3CF696B7313

Q36611620-4E69B4C2-1397-48C2-A6AA-AF58BACCA770

Q36611620-730389A5-D559-4FA0-B937-BDE7E3240611

Q36611620-7B1EE65E-CE91-4F2E-8644-0736A0A24076

Q36611620-7BF56D20-F2A0-43B5-B915-B0DCC973E9C3

P2888

Q36611620-BE4A08D5-5FBE-4003-8A81-8E916D8DF51D

P304

Q36611620-24F85957-109A-4D25-B689-0F580CD87E4F

P31

Q36611620-904815C8-2E56-4A04-B114-30ABABD09D86

P356

Q36611620-7FA1B653-39A2-45B1-A171-7ED644DEB2C5

P407

Q36611620-50D368CF-E881-4DEB-8953-4186B0EDBE7D

P433

Q36611620-39B1CC35-D8F8-45CE-B699-24CD7891FA58

P478

Q36611620-BC2C87BE-E912-4C32-9018-57618E079D94

P50

Q36611620-D15F1A6D-695E-46EA-97A5-43FEBD7F9EC0

P577

Q36611620-D2445BA0-99AD-491E-B025-701AC09634BB

P5875

Q36611620-25152F85-9EE9-471A-B000-051E15D1C0E0

P698

Q36611620-57862E37-CF9D-411A-BD6C-59512EC382ED

P932

Q36611620-9DC8023C-FA90-4CE6-8238-3BB6609FDCB1

P356

P1433

British Journal of Cancer

P1476

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer

@en

P2093

C B H W Lamers

http://www.w3.org/2001/XMLSchema#string

C J H van de Velde

http://www.w3.org/2001/XMLSchema#string

F J G M Kubben

http://www.w3.org/2001/XMLSchema#string

G Griffioen

http://www.w3.org/2001/XMLSchema#string

H W Verspaget

http://www.w3.org/2001/XMLSchema#string

J J van der Reijden

http://www.w3.org/2001/XMLSchema#string

M J W Meijer

http://www.w3.org/2001/XMLSchema#string

M van den Berg

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

A simple salting out procedure for extracting DNA from human nucleated cells

TIMP-2 is required for efficient activation of proMMP-2 in vivo

New functions for the matrix metalloproteinases in cancer progression

Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms.

Matrix metalloproteinase-7 expression in gastric carcinoma.

Matrix metalloproteinases and their inhibitors in gastric cancer.

A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage

P2888

P304

744-751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603307

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Cornelis F.M. Sier

P577

2006-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6847720

http://www.w3.org/2001/XMLSchema#string

P698

16940985

http://www.w3.org/2001/XMLSchema#string

P932

2360506

http://www.w3.org/2001/XMLSchema#string